Ken‐ichi Kayashima

403 citations
15 papers · 267 indexed · h-index 6
Topics
Skin and Cellular Biology Research (2 papers)Cancer and Skin Lesions (2 papers)Nonmelanoma Skin Cancer Studies (2 papers)
Partner nations
Japan

In The Last Decade

Ken‐ichi Kayashima

14 papers receiving 245 citations

Peers

Ken‐ichi Kayashima
Comparison fields: 5 of 68
  • Clinical Biochemistry 82
  • Dermatology 72
  • Molecular Biology 65
  • Oncology 53
  • Cell Biology 44
Replace S. Berti with:
S. Berti Italy
A. Bron France
Mei Ju China
Henrik Sejersen Denmark
Jiehyun Jeon South Korea
Payal Chauhan India
Chang Wook Park South Korea
Michelle Hessen United States
Ragnhild Gullberg Sweden
Tatsuro Miyamoto Japan
Ken‐ichi Kayashima relative to S. Berti Italy S. Berti's profile →
Citations per field
00.5×6.3×
S. Berti · 1×
Citations per year

Countries citing papers authored by Ken‐ichi Kayashima

Since Specialization
Citations

This map shows the geographic impact of Ken‐ichi Kayashima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken‐ichi Kayashima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken‐ichi Kayashima more than expected).

Fields of papers citing papers by Ken‐ichi Kayashima

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ken‐ichi Kayashima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken‐ichi Kayashima. The network helps show where Ken‐ichi Kayashima may publish in the future.

Co-authorship network of co-authors of Ken‐ichi Kayashima

This figure shows the co-authorship network connecting the top 25 collaborators of Ken‐ichi Kayashima. A scholar is included among the top collaborators of Ken‐ichi Kayashima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ken‐ichi Kayashima. Ken‐ichi Kayashima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
#WorkIndexed citations
1 1
2 5
3 2
4 3
5 3
6 121
7 23
8 19
9 1
10 17
11 2
12 5
13 16
14 44
15 5

About Ken‐ichi Kayashima

Ken‐ichi Kayashima is a scholar working on Microbiology, Dermatology and Virology, having authored 15 papers that have together received 267 indexed citations. Recurring topics across this work include Skin and Cellular Biology Research (2 papers), Cancer and Skin Lesions (2 papers) and Nonmelanoma Skin Cancer Studies (2 papers). The work is most often cited by research in Clinical Biochemistry (82 citations), Dermatology (72 citations) and Microbiology (5 citations). Ken‐ichi Kayashima has collaborated with scholars based in Japan. Frequent co-authors include Tomomichi Ono, Kazuyoshi Ikeda, Masayoshi Johno, Kazumoto Katagiri, Sakuhei Fujiwara, Hiroshi Shinkai, Shinji Yamamoto, Kiyofumi Egawa, Paul K. Nakane and Takehiko Koji. Their work appears in journals such as Journal of Investigative Dermatology, Journal of Dermatological Science and American Journal of Dermatopathology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026